Identification of cases and estimate of direct costs of unresectable and advanced cutaneous squamous cell carcinoma: real-world data from a large Italian database

Study type

• Study topic:
  Disease /health condition
• Study type:
  Non-interventional study
• Scope of the study:
  Disease epidemiology

  Healthcare resource utilisation
• Data collection methods:
  Secondary data collection

Non-interventional study

• Non-interventional study design:
  Cohort

Study drug and medical condition

• Medical condition to be studied:
  Squamous cell carcinoma
• Additional medical condition(s):
  Advanced cutaneous squamous cell carcinoma

Study design details

• Main study objective:
  To assess the prevalence of unresectable and advanced (u/a) cSCC and to calculate healthcare costs charged to the Italian National Health Service.
• Setting:
  Inpatient and outpatient settings
• Summary results:
  This real-world study identified patients affected by u/a cSCC and estimated their healthcare costs, filling an information gap. The comparison of demographic data for our cohort with ad hoc information collected by a retrospective study,7 revealed an exact overlapping of sex distribution (67% men) and age (median 78 years) for cSCC cases. An additional important result of our study was the calculation of 1-year direct costs generated by patients affected by u/a cSCC and how these costs compared with those relating to the whole group of advanced cSCCs. In spite of the small number, each of these individuals cost more than €10 000 annually. This finding was unique as most health economic analyses do not differentiate between BCC and cSCC.

Documents

Study publications

Identification of cases and estimate of direct costs of unresectable and advanc…